COVID-19 A rough quarter for leading extractor Valens Slow of demand from clients struggling due to Covid-19 expected to hurt revenues in next quarter as well Nick LabaJuly 16, 2020
COVID-19 BC reduces criminal record check frequency for weed retail The update follows a number of measures introduced by the province in response to added pressures on businesses during the pandemic Nick LabaJuly 15, 2020
The weed wire Inner Spirit hires former Deloitte exec as cannabis gets more corporate MediPharm Labs also taps BMO Capital Markets chief operating officer to its board Jared GnamJuly 15, 2020
The weed wire Mushroom company Mydecine acquires veteran-focused psychedelic firm With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials Jared GnamJuly 15, 2020
The weed wire US weed firm iAnthus slated for debtor takeover Restructuring deal leaves shareholders with a 2.75% stake at best in the U.S. cannabis operator Jared GnamJuly 14, 2020
The weed wire Valens aids new study to verify THC levels in medical weed products The University Health Network study looks to improve cannabinoid testing and dosing for patients Jared GnamJuly 13, 2020
The weed wire Decibel licensed to sell Qwest cannabis extracts Calgary-based firm to sell shatter and wax products under its Qwest craft banner Jared GnamJuly 13, 2020
The weed wire Biden’s new cannabis plan draws ire of advocates Advocacy group says rescheduling plan is like going from treating weed like heroin to treating it like cocaine Jared GnamJuly 10, 2020
The weed wire Second Cup converts first café to cannabis Marking the first conversion since the struggling coffee company announced plans in 2018 Nick LabaJuly 10, 2020
The weed wire Hexo makes first international medical weed shipment to Israel Canadian producer says 493 kilograms of medical cannabis was shipped to Israeli company Breath of Life Jared GnamJuly 10, 2020